Reports
Sale
Global Epigenetics Market Size, Share, Trends, Forecast: By Product: Kits, Reagents, Enzymes, Instruments; By Application: Oncology, Non-Oncology; By End Use: Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, Contract Research Organisations; Regional Analysis; Competitive Landscape; 2024-2032
Global Epigenetics Market Outlook
The global epigenetics market stood at a value of around USD 1,285.68 million in 2023. The market is further expected to grow at a CAGR of 13.8% in the forecast period of 2024-2032 to attain a value of USD 4,100.62 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Kits Segment to Possess a Substantial Share of the Global Epigenetics Industry
Based on product, the kits segment holds a significant share in the global epigenetics industry. This growth can be attributed to the important role of kits in the entire epigenetic analysis process. Furthermore, this number is further expected to rise in the forecast period due to the increasing chronic illnesses and the growing geriatric population rates, which is very susceptible to acquiring various diseases, including cardiovascular diseases or cancer. Meanwhile, the oncology segment is estimated to observe a healthy growth in terms of application due to the high usage of epigenetic research in the oncology field.
North America to Account for a Significant Market Share of the Global Epigenetics Industry
North America is predicted to occupy a considerable share of the global epigenetics industry. This surge can be attributed to the increased utilisation of epigenetic research in the region and the increased investments in the development of the healthcare sector. Another factor influencing the market growth is the rising geriatric population in the region, who are susceptible to chronic diseases such as Parkinson’s disease and cancer.
Epigenetics: Market Segmentation
Epigenetics is an emerging scientific area of study that analyses how environmental influences impact the expression of genes. Based on different environmental experiences, genes are activated and deactivated by cells without any change in the underlying DNA structure of the organism and predict which proteins are transcribed. These external environmental stimuli can affect the genes, which could influence diseases. In addition, research has indicated that many human diseases occur due to the interaction between genetic variants and environmental exposure, such as autism, Parkinson’s disease, and breast cancer, among others.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By product, the market is divided into:
- Kits
- Reagents
- Enzymes
- Instruments
Kits are further divided by type into ChIP sequencing kits, bisulfite conversion kits, whole genome amplification kits, 5-hmC & 5-mC analysis kits, and RNA sequencing kits, among others. At the same time, reagents are further segmented by type into antibodies, magnetic beads, histones, buffers, primers, and others. Meanwhile, enzymes are categorised by type into DNA polymerases, DNA ligases, methyltransferases, acetylases, and reverse transcriptase, among others. And instruments are segregated by type into next-generation sequencers, qPCRs, mass spectrometers, sonicators, and others.
On the basis of application, the industry can be categorised into:
- Oncology
- Non-Oncology
Oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is segmented by type into metabolic diseases, infectious diseases, inflammatory diseases, cardiovascular diseases, and others.
Based on end use, the market can be segmented into:
- Academics and Research Institutes
- Pharmaceutical and Biotechnology Companies
- Contract Research Organisations
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Increasing Prevalence of Cardiovascular Diseases to Augment the Growth of the Global Epigenetics Industry
According to WHO reports, cardiovascular diseases are the leading cause of death globally, claiming more than 17.9 million lives every year. Cardiovascular diseases are illnesses of heart and blood vessels that are adversely affected by high-risk behaviours such as unhealthy diet, physical inactivity, and substance abuse. In this regard, epigenetic research has found epigenetic biomarkers, a promising tool for the diagnosis and prognosis of many cardiovascular diseases. Some of their promising features include easy accessibility and feasibility in their detection methods, making them applicable for use in clinical interventions. This is significantly contributing to the growth of the market.
In a 2017 research by the American Diabetes Association, the researchers concluded that diabetes is a complication developed from the interaction of DNA structure variation and the environmental stimuli that causes changes in the cellular phenotype.
Key Industry Players in the Global Epigenetics Market
The report gives a detailed analysis of the following key players in the global epigenetics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Abcam Plc
- Active Motif, Inc.
- Agilent Technologies, Inc.
- Diagenode S.A.
- QIAGEN GmbH
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Application |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Epigenetics Market Analysis
8.1 Key Industry Highlights
8.2 Global Epigenetics Historical Market (2018-2023)
8.3 Global Epigenetics Market Forecast (2024-2032)
8.4 Global Epigenetics Market by Product
8.4.1 Kits
8.4.1.1 Historical Trend (2018-2023)
8.4.1.2 Forecast Trend (2024-2032)
8.4.1.3 Breakup by Type
8.4.1.3.1 ChIP Sequencing Kits
8.4.1.3.2 Bisulfite Conversion Kits
8.4.1.3.3 Whole Genome Amplification Kits
8.4.1.3.4 5-hmC & 5-mC Analysis Kits
8.4.1.3.5 RNA Sequencing Kits
8.4.1.3.6 Others
8.4.2 Reagents
8.4.2.1 Historical Trend (2018-2023)
8.4.2.2 Forecast Trend (2024-2032)
8.4.2.3 Breakup by Type
8.4.2.3.1 Antibodies
8.4.2.3.2 Magnetic Beads
8.4.2.3.3 Histones
8.4.2.3.4 Buffers
8.4.2.3.5 Primers
8.4.2.3.6 Others
8.4.3 Enzymes
8.4.3.1 Historical Trend (2018-2023)
8.4.3.2 Forecast Trend (2024-2032)
8.4.3.3 Breakup by Type
8.4.3.3.1 DNA Polymerases
8.4.3.3.2 DNA Ligases
8.4.3.3.3 Methyltransferases
8.4.3.3.4 Acetylases
8.4.3.3.5 Reverse Transcriptase
8.4.3.3.6 Others
8.4.4 Instruments
8.4.4.1 Historical Trend (2018-2023)
8.4.4.2 Forecast Trend (2024-2032)
8.4.4.3 Breakup by Type
8.4.4.3.1 Next generation sequencers
8.4.4.3.2 qPCRs
8.4.4.3.3 Mass Spectrometers
8.4.4.3.4 Sonicators
8.4.4.3.5 Others
8.5 Global Epigenetics Market by Application
8.5.1 Oncology
8.5.1.1 Historical Trend (2018-2023)
8.5.1.2 Forecast Trend (2024-2032)
8.5.1.3 Breakup by Type
8.5.1.3.1 Solid Tumors
8.5.1.3.2 Liquid Tumors
8.5.2 Non-Oncology
8.5.2.1 Historical Trend (2018-2023)
8.5.2.2 Forecast Trend (2024-2032)
8.5.2.3 Breakup by Type
8.5.2.3.1 Metabolic Diseases
8.5.2.3.2 Infectious Diseases
8.5.2.3.3 Inflammatory Diseases
8.5.2.3.4 Cardiovascular Diseases
8.5.2.3.5 Others
8.6 Global Epigenetics Market by End Use
8.6.1 Academic and Research Institutes
8.6.1.1 Historical Trend (2018-2023)
8.6.1.2 Forecast Trend (2024-2032)
8.6.2 Pharmaceutical and Biotechnology Companies
8.6.2.1 Historical Trend (2018-2023)
8.6.2.2 Forecast Trend (2024-2032)
8.6.3 Contract Research Organisations
8.6.3.1 Historical Trend (2018-2023)
8.6.3.2 Forecast Trend (2024-2032)
8.7 Global Epigenetics Market by Region
8.7.1 North America
8.7.1.1 Historical Trend (2018-2023)
8.7.1.2 Forecast Trend (2024-2032)
8.7.2 Europe
8.7.2.1 Historical Trend (2018-2023)
8.7.2.2 Forecast Trend (2024-2032)
8.7.3 Asia Pacific
8.7.3.1 Historical Trend (2018-2023)
8.7.3.2 Forecast Trend (2024-2032)
8.7.4 Latin America
8.7.4.1 Historical Trend (2018-2023)
8.7.4.2 Forecast Trend (2024-2032)
8.7.5 Middle East and Africa
8.7.5.1 Historical Trend (2018-2023)
8.7.5.2 Forecast Trend (2024-2032)
9 North America Epigenetics Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2018-2023)
9.1.2 Forecast Trend (2024-2032)
9.2 Canada
9.2.1 Historical Trend (2018-2023)
9.2.2 Forecast Trend (2024-2032)
10 Europe Epigenetics Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2018-2023)
10.1.2 Forecast Trend (2024-2032)
10.2 Germany
10.2.1 Historical Trend (2018-2023)
10.2.2 Forecast Trend (2024-2032)
10.3 France
10.3.1 Historical Trend (2018-2023)
10.3.2 Forecast Trend (2024-2032)
10.4 Italy
10.4.1 Historical Trend (2018-2023)
10.4.2 Forecast Trend (2024-2032)
10.5 Others
11 Asia Pacific Epigenetics Market Analysis
11.1 China
11.1.1 Historical Trend (2018-2023)
11.1.2 Forecast Trend (2024-2032)
11.2 Japan
11.2.1 Historical Trend (2018-2023)
11.2.2 Forecast Trend (2024-2032)
11.3 India
11.3.1 Historical Trend (2018-2023)
11.3.2 Forecast Trend (2024-2032)
11.4 ASEAN
11.4.1 Historical Trend (2018-2023)
11.4.2 Forecast Trend (2024-2032)
11.5 Australia
11.5.1 Historical Trend (2018-2023)
11.5.2 Forecast Trend (2024-2032)
11.6 Others
12 Latin America Epigenetics Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2018-2023)
12.1.2 Forecast Trend (2024-2032)
12.2 Argentina
12.2.1 Historical Trend (2018-2023)
12.2.2 Forecast Trend (2024-2032)
12.3 Mexico
12.3.1 Historical Trend (2018-2023)
12.3.2 Forecast Trend (2024-2032)
12.4 Others
13 Middle East and Africa Epigenetics Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2018-2023)
13.1.2 Forecast Trend (2024-2032)
13.2 United Arab Emirates
13.2.1 Historical Trend (2018-2023)
13.2.2 Forecast Trend (2024-2032)
13.3 Nigeria
13.3.1 Historical Trend (2018-2023)
13.3.2 Forecast Trend (2024-2032)
13.4 South Africa
13.4.1 Historical Trend (2018-2023)
13.4.2 Forecast Trend (2024-2032)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Abcam Plc
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Active Motif, Inc.
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 Agilent Technologies, Inc.
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Diagenode S.A.
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 QIAGEN GmbH
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Epigenetics Market: Key Industry Highlights, 2018 and 2032
2. Global Epigenetics Historical Market: Breakup by Product (USD Million), 2018-2023
3. Global Epigenetics Market Forecast: Breakup by Product (USD Million), 2024-2032
4. Global Epigenetics Historical Market: Breakup by Application (USD Million), 2018-2023
5. Global Epigenetics Market Forecast: Breakup by Application (USD Million), 2024-2032
6. Global Epigenetics Historical Market: Breakup by End Use (USD Million), 2018-2023
7. Global Epigenetics Market Forecast: Breakup by End Use (USD Million), 2024-2032
8. Global Epigenetics Historical Market: Breakup by Region (USD Million), 2018-2023
9. Global Epigenetics Market Forecast: Breakup by Region (USD Million), 2024-2032
10. North America Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2023
11. North America Epigenetics Market Forecast: Breakup by Country (USD Million), 2024-2032
12. Europe Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2023
13. Europe Epigenetics Market Forecast: Breakup by Country (USD Million), 2024-2032
14. Asia Pacific Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2023
15. Asia Pacific Epigenetics Market Forecast: Breakup by Country (USD Million), 2024-2032
16. Latin America Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2023
17. Latin America Epigenetics Market Forecast: Breakup by Country (USD Million), 2024-2032
18. Middle East and Africa Epigenetics Historical Market: Breakup by Country (USD Million), 2018-2023
19. Middle East and Africa Epigenetics Market Forecast: Breakup by Country (USD Million), 2024-2032
20. Global Epigenetics Market Structure
Key Questions Answered in the Report
In 2023, the global epigenetics market attained a value of nearly USD 1,285.68 million.
The market is projected to grow at a CAGR of 13.8% between 2024 and 2032.
The major drivers of the industry such as increased investment in the research and development of epigenetic interventions, increasing chronic illnesses, increased application of epigenetic analysis mechanisms in the oncology field, and rising ageing population globally are expected to aid the market growth.
The key market trends guiding the industry's growth include the increasing incidences of cardiovascular diseases and increased utilisation of epigenetic research.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product segments can be divided into kits, reagents, enzymes, and instruments.
The significant applications of the product include oncology and non-oncology. The oncology segment is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others.
The major segments based on end-use include academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations.
The major players in the industry are Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.
Analyst Review
The global epigenetics market attained a value of USD 1,285.68 million in 2023, driven by the growing incidences of cardiovascular diseases globally. Aided by the rapidly growing geriatric population and the technological advancements, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 13.8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By products, the market can be distributed into kits, reagents, enzymes, and instruments. On the basis of applications, the industry can be segmented into oncology and non-oncology. Among this oncology is further divided by type into solid tumours and liquid tumours, whereas non-oncology is distributed by type into metabolic disease, infectious diseases, inflammatory diseases, and cardiovascular diseases, among others. Based on end-use, the market can be categorised into academics and research institutes, pharmaceutical and biotechnology companies, and contract research organisations. The major regional markets for epigenetics market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abcam Plc, Active Motif, Inc., Agilent Technologies, Inc., Diagenode S.A., and QIAGEN GmbH, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER